CORC  > 山东大学
Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
Yang, Renchi; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Hou, Ming
刊名BRITISH JOURNAL OF HAEMATOLOGY
2017
卷号176期号:1页码:101-110
关键词Asian Continental Ancestry Group autoimmune thrombocytopenia blood platelet disorders platelet count treatment outcome
DOI10.1111/bjh.14380
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4586127
专题山东大学
作者单位1.Chinese Acad Med Sci, Inst Haematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China.
2.Chinese Acad Med Sci, Blood Dis
推荐引用方式
GB/T 7714
Yang, Renchi,Li, Junmin,Jin, Jie,et al. Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia[J]. BRITISH JOURNAL OF HAEMATOLOGY,2017,176(1):101-110.
APA Yang, Renchi.,Li, Junmin.,Jin, Jie.,Huang, Meijuan.,Yu, Ziqiang.,...&Hou, Ming.(2017).Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia.BRITISH JOURNAL OF HAEMATOLOGY,176(1),101-110.
MLA Yang, Renchi,et al."Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia".BRITISH JOURNAL OF HAEMATOLOGY 176.1(2017):101-110.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace